over the past decade, nanopores have rapidly emerged as stochastic biosensors. this protocol describes the cloning, expression and purification of the channel of the bacteriophage phi29 Dna-packaging nanomotor and its subsequent incorporation into lipid membranes for single-pore sensing of double-stranded Dna (dsDna) and chemicals. the membrane-embedded phi29 nanochannel remains functional and structurally intact under a range of conditions. When ions and macromolecules translocate through this nanochannel, reliable fingerprint changes in conductance are observed. compared with other well-studied biological pores, the phi29 nanochannel has a larger cross-sectional area, which enables the translocation of dsDna. Furthermore, specific amino acids can be introduced by site-directed mutagenesis within the large cavity of the channel to conjugate receptors that are able to bind specific ligands or analytes for desired applications. the lipid membrane-embedded nanochannel system has immense potential nanotechnological and biomedical applications in bioreactors, environmental sensing, drug monitoring, controlled drug delivery, early disease diagnosis and high-throughput Dna sequencing. the total time required for completing one round of this protocol is around 1 month.
IntroDuctIon
DNA, RNA and proteins have intrinsically defined features at the nanometer scale and can serve as building blocks for bottom-up fabrication of nanostructures in materials engineering and synthetic biology. The DNA-packaging motor of the bacteriophage phi29 (Fig. 1a,b ) uses a hexameric packaging RNA (pRNA) ring and an ATP-dependent enzyme as the motor-gearing components. The motor contains a so-called connector that forms a channel serving as a path for dsDNA translocation. The phi29 nanomotor was reconstituted in a defined system over 20 years ago 1 and remains one of the most well-studied systems. It is also one of the most powerful molecular motors, generating forces up to 57-110 pN (refs. 2,3) . A number of biophysical and structural studies of the phi29 motor have been carried out over the past three decades in Peixuan Guo's laboratory. Results from these studies include the construction of the bacteriophage phi29 DNA-packaging motor in vitro 1 ; discovery of the phi29 motor pRNA 4 ; assembly of infectious viruses of phi29 in vitro using purified components of the DNA-packaging motor 5 ; and elucidation of the formation of the pRNA hexamer [6] [7] [8] [9] , an achievement that laid the foundation for RNA nanotechnology [10] [11] [12] [13] .
Explicit protein engineering via site-directed mutagenesis of the phi29 connector is possible because the crystal structure of the wild-type connector has been elucidated [14] [15] [16] . It is therefore feasible to reengineer the connector by introducing specific binding elements at strategic positions (at the C or N termini or in the interior of the channel) for desired applications [17] [18] [19] . The phi29 connector consists of 12 subunits of the gp10 protein, which form a central channel that is shaped like a hollow, truncated cone. The native connector's wider C-terminal end is buried within the procapsid, whereas its narrow N-terminal end partially protrudes out of the procapsid. The central pore has a cross-sectional area of 10 nm 2 (3.6 nm in diameter) at the narrow end and 28 nm 2 (6 nm in diameter) at the wide end [14] [15] [16] (Fig. 1c,d ).
Surface charge analysis of the connector revealed that its central region is slightly hydrophobic compared with the flanking hydrophilic C and N termini 20 . The wild-type connector was reengineered to include a His-tag (for affinity purification) downstream of a six-glycine linker (for affinity tag flexibility) at the N or C terminus. The modified connector retained its 12-fold symmetric structure and its ability to package DNA after incorporation into the procapsid. The reengineered phi29 connector was then inserted into a lipid bilayer 20 . The resulting bilayer-embedded nanopore system is robust and generates extremely reliable, precise and sensitive current signatures when ions or DNA pass through the channel, as revealed by single-channel conductance measurements [20] [21] [22] [23] [24] . The pore sizes of reengineered channels are nearly identical from sample to sample, which demonstrates the extreme reproducibility of the approach at the atomic level 20, 21, 23 . Within the large cavity of the pore, substrate-specific functionalities can be introduced by chemical conjugation with relative ease 25 . The procedures for large-scale production and purification of the connector have also been developed 17, [26] [27] [28] [29] . This protocol focuses on the cloning, expression and purification of the reengineered connector protein and its insertion into a lipid membrane setup, thereby creating a robust lipid bilayer-embedded nanopore platform that is capable of single-molecule detection of biopolymers and chemicals.
Comparison with other methods
Over the years, besides phi29 channels, several other biological pores have been extensively used for nanopore-based sensing applications. These include α-hemolysin, Mycobacterium smegmatis porin A (MspA) and, more recently, ferric hydroxamate uptake component A (FhuA) channels. The crystal structures of these four channels are available, and thus rational modifications by site-directed mutagenesis or chemical means can be carried out to reengineer mutant channels for desired applications 20, [30] [31] [32] [33] [34] . Some fundamental differences exist between these channels with respect to structure and biophysical characteristics, especially with regard to nucleic acid translocation.
α-Hemolysin is a heptameric transmembrane pore that consists of an extramembranal cap connected to a transmembrane β-barrel. The narrowest cross-section of the hollow part of the pore is at the vestibule-transmembrane domain junction with a diameter of ~1.4 nm (ref. 35) . To date, α-hemolysin has been the benchmark for sensing an extremely wide range of analytes, from metal ions to organic molecules to DNA, RNA and peptides [36] [37] [38] [39] [40] [41] . Another nanopore is MspA, which is an octameric, funnel-shaped channel with a diameter of ~1.2 nm at the narrowest point and a length of ~0.5 nm (ref. 30) . α-Hemolysin and MspA are both very robust pores and retain channel-forming ability even at extreme pH (pH 2-12) and high temperatures (close to 100 °C) 42, 43 . Given their small pore sizes at the narrowest constriction, the research applications of α-hemolysin and MspA are limited to the translocation of single-stranded DNA (ssDNA), as dsDNA has a width of ~2 nm. Although some evidence exists that some channels are capable of dsDNA transport [44] [45] [46] , these nanopores have limited sensing applications because of their gating properties and variations in open-pore currents as a result of protein conformational changes, as well as in response to changes in electric potential difference and fluctuations in conductance (defined as the ratio of current and voltage; the reciprocal of resistance) under various experimental conditions.
Over the past couple of years, FhuA, a larger transmembrane β-barrel protein derived from the outer membrane of Escherichia coli, has been inserted into a lipid bilayer to serve as a nanopore 33, 47 . Compared with other channels, FhuA channels are monomeric in nature and are characterized by an elliptically shaped barrel (crosssectional dimensions ~3.1 nm × 4.4 nm) 33, 47 . Heavily reengineered FhuA channels remain active and structurally intact under a wide range of experimental conditions, and thus they can potentially be used for diverse purposes, such as examining the proteolytic activity of enzymes and studying protein-DNA kinetics 33 . However, the capability of FhuA channels to translocate dsDNA has yet to be demonstrated.
To achieve cross-membrane translocation of dsDNA, some researchers have switched to fabricating synthetic pores [48] [49] [50] [51] [52] . The phi29 connector channel is the first viral protein channel that is neither a membrane protein nor an ion channel that has been reconstituted into a lipid bilayer 20 . Bilayer-embedded connector channels show biophysical and biochemical robustness under different experimental conditions, as revealed by single-channel conductance measurements [20] [21] [22] [23] [24] [25] . The key advantage of the phi29 nanochannel with respect to the aforementioned systems is that it has a larger channel diameter, and hence it can easily translocate dsDNA and ssDNA. Furthermore, the large cavity size of this channel enables the relatively easy insertion of functional moieties with desirable characteristics via conjugation to amino acid residues lining the channel cavity or at the terminal ends for diverse applications.
Unlike the cases of α-hemolysin, MspA and FhuA, which can form protein channels in lipid membrane by simultaneous assembly and direct insertion, lipid membrane insertion of phi29 connector channels is a two-step process. The first step consists in the reconstitution of purified reengineered connectors into liposomes, and the second in the fusion of proteoliposomes with a planar lipid bilayer 20 . The resulting system can then be studied by single-channel conduction assay using a conventional patch-clamp setup, as used in other nanopore systems. Instrumentation and setup design protocols for synthetic and protein nanopore systems have been described previously 53 . In general, the setup for electrophysiological assays requires the following: (i) a Faraday cage, to shield the assay setup from electromagnetic interference; (ii) a vibration-isolating air table, to shield the assay setup from mechanical vibrations; (iii) a high-quality amplifier, to amplify and filter the electric current signal; (iv) data acquisition hardware and software; (v) membrane support (such as bilayer cuvettes and chambers); (vi) a source of illumination (for instance, a halogen lamp); (vii) a stir plate; (viii) a perfusion system, to exchange solutions; and (ix) a thermocycler, to control temperature.
Potential applications
The protocol described herein on the cloning, expression and purification of the reengineered portal channel proteins, and their subsequent insertion into lipid membranes, can also be applied to portal channel proteins from other bacteriophages, such as SPP1, T3, T4, T5, T7, HSV-1, T7, ε15, λ and P22, for desired nanotechnology and biotechnology applications 54 .
Nanopore-based sensing has a wide range of potential applications, such as in the sensing of species as minute as single molecules of chemicals or as large as individual biopolymers [55] [56] [57] [58] . The single-molecule recognition approach that involves the use of nanopores is high throughput and label-free; it requires very little sample volume and does not involve any sample preparations or modifications. Over the past decade, nanopore-based sensory techniques have been extensively used for diverse applications, • The gel needs to be freshly prepared. ! cautIon Ethidium bromide is a 3| Purify the 6,111-bp fragment, which contains the gene encoding gp10, by electroelution from a 0.8% (wt/vol) agarose gel as follows. Stain the agarose gel for 20 min in ethidium bromide staining solution at RT. Move the stained agarose gel under ultraviolet light. Excise out the front part of the leading edge of the 6,111-bp DNA band. This excision will cause the formation of a well in front of the band. Try to keep the width of the well as narrow as possible (typically < 0.5 mm). Insert a dialysis membrane into the excised well and push it under the agarose gel where the 6,111-bp DNA is positioned. Fill the well to the top of the gel with TAE buffer. Resume electrophoresis for ~15 min at 150 V until the DNA band has moved out of the gel and into the well. Switch electrodes to apply reverse electrical field for 30 s at 150 V. Stop the electrophoresis and pipette out the DNA solution from the well carefully. Centrifuge the solution from the well for 5 min at 13,000g force to cause the precipitation of any agarose gel remnants, and collect the supernatant. ! cautIon Ethidium bromide is a strong carcinogen; it is a skin, eye and respiratory tract irritant. Wear gloves and dispense in the hood.
4|
Concentrate the DNA fragment from Step 3 by centrifugation using Centricon-YM-30 tubes (follow the manufacturer's guidelines), and purify the DNA using the Qiaex II gel extraction kit (follow the manufacturer's guidelines).
5| Digest the resulting DNA fragment with EcoRI (cut site 9862) according to the enzyme manufacturer's guidelines. This restriction will produce two fragments of 4,670 and 1,441 bp.
6|
Restrict 1 µg of plasmid pBluescript (KS +) with EcoRI and SmaI according to the enzyme manufacturer's instructions.
7|
Purify the 1,441-bp EcoRI/SnaBI fragment from Step 5, which contains parts of gene 10, from 0.8% (wt/vol) agarose gel (see Step 3) . Insert the purified DNA fragment into the EcoRI/SmaI site of pBluescript (KS +) to generate plasmid pBlue10 using T4 DNA ligase (according to the enzyme manufacturer's instructions).
8| Restrict 1 µg of plasmid pBluescript (KS +) with EcoRI and XhoI according to the enzyme manufacturer's guidelines.

9|
The 4,670-bp DNA fragment, which contains part of gene 10, had an XhoI linker ligated to the ScaI blunt end. Ligate this fragment into the vector pBluescript (KS +) at the EcoRI/XhoI site using T4 DNA ligase (according to the manufacturer's instructions), thereby generating plasmid pBlueXhoI. 
10|
12|
Ligate the two purified DNA fragments (from Steps 10 and 11) into the EcoRI/BamHI sites of pBlueXhoI in order to generate plasmid pBlue6K using T4 DNA ligase (according to the manufacturer's instructions). The plasmid pBlue6K will contain the two fragments, 1,441 bp (excised from pBlue10) and 4,670 bp (excised from pBlueXhoI).
13| Transform the plasmid into E. coli cells HMS174 (ref. 83).
14| Restrict 1 µg of plasmid pBlue6K with NheI/BamHI by following the enzyme manufacturer's guidelines. Purify the 5,643-bp NheI/BamHI fragment from 0.8% (wt/vol) agarose gel (see Step 3).
15|
Restrict 1 µg of plasmid pARgp7 (refs. 5,80-82,81-83) with NheI/BamHI by following the enzyme manufacturer's guidelines. Ligate the 5,643-bp NheI/BamHI fragment from Step 14 to plasmid pARgp7 at the NheI/BamHI sites using T4 DNA ligase (according to the enzyme manufacturer's instructions) to generate plasmid pARgp7-8-8.5-10.
16| Transform the plasmid into E. coli cells HMS174 (ref. 83).
17| Restrict 1 µg of plasmid pARgp7-8-8.5-10 with XbaI, following the enzyme manufacturer's guidelines. Remove the XbaI fragment via 0.8% (wt/vol) agarose gel. Self-ligate the plasmid using T4 DNA ligase to produce a plasmid pAR10. (ii) Use the first PCR product as a template for a second step of PCR with primers F1, which contains the restriction site for NdeI, and R2, which contains an affinity Strep-tag and the restriction site for XhoI (Fig. 2) . Use ~1 µl of 1 nM DNA template and 10 µl of 100 µM (each) primer for a 200-µl PCR reaction and follow the same PCR protocol as in Step 18A(i).
(B) Introduction of a terminal His-tag
(i) To introduce the His-tag at the terminal of the connector protein gp10, only a one-step PCR is necessary. Use the primer pair F1-R3 to amplify the gp10 gene by following the same PCR protocol as mentioned in Step 18A (Fig. 2c) .
19| Purify the PCR product by 0.8% (wt/vol) agarose gel (see Step 3) , and then digest the DNA product with NdeI and XhoI according to the enzyme manufacturer's directions.
20|
Digest the vector pET-21a( + ) with NdeI and XhoI by following the enzyme manufacturer's instructions.
21| Ligate the PCR product from
Step 19 into the digested vector pET-21a( + ) from Step 20 to generate plasmid pETgp10-C-strep or pETgp10-C-His using T4 DNA ligase (according to the manufacturer's instructions).
22|
Transform the ligated mixture into competent E. coli DH5α cells to amplify plasmid DNA according to the cell manufacturers' directions.
23|
Purify the plasmid DNA extracted from transformed DH5α cells using the Plasmid Maxiprep purification kit (according to the manufacturer's instructions).
24|
Verify the recombinant DNA sequence by sequencing it (for example, using Genwiz). expression and purification of the reengineered phi29 connector • tIMInG ~3 d 25| Transform E. coli strain HMS174 (DE3), by following the cell manufacturers' directions, with plasmid pETgp10-C-His for His-tagged connector protein or pETgp10-C-strep for Strep-tagged connector protein. Incubate this at 37 °C overnight.
26| Incubate a colony from the plate in 10 ml of LB medium containing 50 µg ml − 1 ampicillin at 37 °C with shaking at 250 r.p.m. until the optical density at 600 nm (OD 600 ) reaches 0.5-0.6 (~3 h).
27|
Dilute the cell culture at least 100-fold. Induce expression of the connector protein by adding IPTG to a final concentration of 0.5 mM and continue incubation for an additional 3 h. At this stage, the entire connector should assemble from its 12 subunits.
28|
Test the induction of phi29 connector protein by 12% (wt/vol) SDS-PAGE. To achieve this goal, take 100-µl samples from preinduction culture (Step 27, used as negative control) and postinduction culture (at the endpoint of this step). Mix 10 µl of each preinduction and postinduction sample with 10 µl of 2× SDS-PAGE loading buffer and heat them at 100 °C for 1 min before loading them onto the gel. The molecular weight of one subunit of wild-type phi29 connector is 35 kDa, whereas the molecular weights of the C-strep-modified connector and C-His-modified connectors are 37.3 and 36.7 kDa, respectively.
29|
Collect the postinduction cells from the culture described in Step 27 by centrifugation at 6,500g for 30 min at 4 °C, and then discard the supernatant.  pause poInt The cell pellets can be stored at − 70 °C for several days.
30|
Resuspend the cell pellet in 25 ml of cell-washing buffer.
31|
Lyse the resuspended cells in a French press at 12,000 p.s.i. (83 MPa). For complete lysis, pass the cells through the French press three consecutive times.
32|
Remove genomic DNA and RNA from the cell suspension resulting from Step 31 by adding DNase I to a final concentration of 5 µg ml − 1 and RNase A to a final concentration of 10 µg ml − 1 . Keep the resulting mixture at 4 °C for 1 h.
33|
Centrifuge the lysed cells at 18,800g for 30 min at 4 °C. Collect the supernatant carefully without disturbing the pellet and store it at 4 °C.  crItIcal step Ensure that the supernatant is not cloudy, or it will block the columns used in Step 35 below. 34| (Optional) If the supernatant is cloudy, centrifuge it one more time as detailed in Step 33.
35|
Choose a resin for the purification column according to the affinity tag introduced in the connector. For example, choose the Strep-tactin resin for a Strep-tag, and His-bind resin for a His-tag. Resuspend the appropriate resin gently by swirling. Add 2 ml of slurry to a Bio-Rad Poly-Prep column and wait for it to settle overnight at 4 °C.
36|
Equilibrate the column at 4 °C by adding 10 ml of cell-washing buffer to it. While keeping the system temperature at 4 °C, load the supernatant from Step 33 and wash it with 10 ml of cell-washing buffer.
37| Elute the supernatant with 5 ml of elution buffer and collect 500-µl fractions of eluted solution while keeping the system at 4 °C.  crItIcal step Carry out washing and elution steps at 4 °C (in a cold room) to avoid protein degradation. ATP presence in the cell-washing buffer is essential in order to keep the protein soluble. A soluble connector is particularly important when preparing the liposome/connector complex (see below).
38|
To test whether the connector has been eluted, and in which fractions, mix 10-µl samples of each eluted fraction with 10 µl of 2× SDS loading buffer and, after boiling the resulting solutions for 2 min, load them onto a 12% (wt/vol) SDS-PAGE gel. Next, run an electrophoresis experiment. ? trouBlesHootInG  pause poInt Aliquot the purified connector proteins and store them at − 80 °C. The aliquots remain stable for several years.
Fluorescence labeling of the reengineered phi29 connector • tIMInG ~1 d 39| For small-scale FITC conjugation, dissolve ~1 mg of connector protein in elution buffer to obtain a 1-ml solution of connector.
40| Dialyze the solution obtained in
Step 39 against 1,000 ml of PBS (pH 7.4) at 4 °C overnight.
41|
Add 0.1 ml of 1 M carbonate-bicarbonate buffer (provided in the FITC conjugation kit) to 0.9 ml of connector protein in PBS, so that the final concentration of the carbonate-bicarbonate buffer is 0.1 M, at pH 9.0. 
42|
43|
Remove free FITC using 3.5 ml of G-25 Sephadex columns (provided in the FITC conjugation kit). Equilibrate the column with PBS buffer and elute the connector protein using 2.5 ml of PBS. Collect fractions (0.25 ml each) and measure the absorbance of each fraction at 280 nm using a UV-vis spectrophotometer. Combine the fractions containing the connector. 
50|
Rehydrate the lipid film by adding 2 ml of filtered 200 mM sucrose solution.
51| Prepare GUVs according to option A, which yields nonuniform-sized GUVs that are nonetheless suitable for studying biological membranes and their properties, or according to option B, which is an electro-swelling approach that gives a near-uniform size distribution of GUVs. In addition, please note that, by applying option B, the size of the GUVs can be controlled with relative ease for desired application by tuning the voltage amplitude and frequency. 
52|
To prepare GUVs without connector protein (control), rehydrate the lipid film with 2 ml of filtered 200 mM sucrose solution, and then implement Step 51A or B.
53|
To prepare GUVs with a connector protein, add 100 µl of 1 mg ml − 1 FITC-labeled (for imaging) or unlabeled (for conduction assays) reengineered connectors in a 200 mM sucrose solution to the dried lipid with a final lipid:connector mole ratio of 75:1, and then implement Step 51A or B.
54| Take an aliquot from the middle of each of the solutions from Steps 52 and 53 and transfer each aliquot into a different Petri dish. Image the FITC-labeled proteoliposomes (or NBD-labeled giant vesicles, if
Step 48 was implemented) by epifluorescence microscopy. The typical diameter of the vesicles is in the 20-50-µm range (Fig. 3a) .  pause poInt Store the giant vesicles at 4 °C, as they remain stable at this temperature for up to 3 d. (Fig. 3b) .
preparation of small unilamellar vesicles (suVs) containing the reengineered phi29 connector • tIMInG ~5 h 57| Add 1 ml of 1 mg ml − 1 DOPC or DPhPC lipids in chloroform into a 2-ml glass vial by means of a syringe. Implement
Step 49A or B to remove the chloroform.
58|
Rehydrate the lipid film with 1 ml of proteoliposome rehydration buffer containing the reengineered connector protein (concentration 0.5 mg ml − 1 ); vortex thoroughly. 59| Extrude the rehydrated protein-lipid complex with a mini-extruder (follow the manufacturer's instructions) through polycarbonate membranes (100 or 400 nm) to generate SUVs. Aliquot the extruded proteoliposomes (~50 µl in each tube).  pause poInt For long-term storage (up to several years), keep the SUVs at − 80 °C. For short-term storage (up to a few weeks), place SUVs at 4 °C.
setup for electrophysiological assays • tIMInG ~1 h, but initial setup can take several days 60| Rinse a pair of Ag/AgCl electrodes with ethanol and water. Immerse the electrode pellets in Clorox bleach until a light gray color is observed on the electrode surface. Typically, 10-15 min will be sufficient.  crItIcal step Do not store the electrodes in contact with metals. Avoid exposing the electrodes to light.
61|
Connect the electrodes directly to the head-stage of a patch-clamp current amplifier. Record the trace using an Axopatch 200B patch-clamp amplifier coupled with the Axon DigiData 1322A or Axon DigiData 1440 analog-digital converter.
62|
Acquire the low-pass-filtered data at a frequency of 1-10 kHz and sampling frequency of 2-200 kHz, as needed. Use PClamp Clampex software to collect the data, and then use Clampfit software for data analysis.  crItIcal step Set the sampling frequency so that its value is at least five times higher than the filter cutoff frequency in order to avoid possible sampling artifacts.
cleaning the BlM chamber and partition • tIMInG ~30 min 63| Prerinse the chambers with deionized water to remove any chemicals. Forcefully squirt the chambers with BLM cleaning solution 1 (containing TSP) to remove any solid residues. Next, rinse the chambers with BLM cleaning solution 2 to remove residual phosphates. Finally, wash them with Milli-Q water to remove any residual HCl. Dry everything with an air stream.
64| (Optional) For heavy-duty cleaning, sonicate the top chamber in ethanol for 10 min. Rinse it briefly with ethanol and thoroughly with Milli-Q water.
65|
Incubate the Teflon partition in a test tube with n-decane for 2 min at RT. Assemble the partition on the chamber using vacuum grease. Vortex to remove the grease completely. Rinse the partition twice with n-decane, twice with ethanol and twice with nanopure water. Let it air-dry on a Kimwipe.  crItIcal step For single-molecule analysis, it is important to ensure that the chambers and partitions are cleaned thoroughly to eliminate artifacts arising from contaminants.
electrophysiological chamber assembly and experiment setup • tIMInG ~2 h 66| Assemble horizontal chambers (Eastern Scientific, BCH-1A, option A) or vertical chambers (Warner instruments, BCH-13A, option B) to conduct electrophysiological assays (Fig. 4) . The two setups are essentially equivalent for the purposes of this protocol. 67| Pre-paint both sides of the Teflon partition or cuvette with lipid solution A (typically less than 0.5 µl is sufficient). Wait for 20-40 min for it to dry. Repeat this step one more time.
68|
For the horizontal chamber setup, fill the cis-and trans-compartments with 0.25 and 2 ml of conduction buffer, respectively. For the vertical chamber setup, fill both compartments with 1 ml of conduction buffer. Place the head-stage Ag/AgCl electrode in the trans-compartment and the ground Ag/AgCl electrode in the cis-compartment.
69| (Optional) Connect the Ag/AgCl electrodes to the cis-and trans-compartments using salt bridges (Fig. 4a, right) . This setup serves two purposes: it facilitates electrical coupling with the amplifier and minimizes the transfer of ions or solute from the cis/trans-compartment to electrode wells.
70| (Optional) Set up a bilayer perfusion system (follow the manufacturer's guidelines) to enable automated, efficient and rapid exchange of buffers in cis-and trans-compartments.
71| (Optional) Set up a bilayer thermocycler (follow the manufacturer's guidelines) to conduct single-channel measurements at any temperature between 5 and 50 °C.
72|
Place the chamber setup on a rubber mat. Place the whole assembly (Fig. 4a) inside a Faraday cage, so as to shield it from electrical and mechanical interference.  crItIcal step Ensure that all the instruments are connected to a common ground and that the ground connection is isolated from all circuits.
? trouBlesHootInG 73| Familiarize yourself with the instrument control panel before use. Calibrate and set the desired parameters (using guidelines from the manufacturer).
Insertion of the connector into the planar bilayer lipid membrane • tIMInG ~1-2 h 74|
To paint a planar membrane, first locate the aperture in the Teflon partition (horizontal chamber) or cuvette (vertical chamber) with an optical microscope. Next, pipette 1-2 µl of lipid solution B into the aperture by placing the tip of the pipette close to the aperture and gently squeezing the lipids out. The membrane should form spontaneously within a few seconds. 75| Remove excess lipid from the aperture. To do so, place the pipette near the side of the aperture and squeeze out air bubbles from the pipette. Gently brush against the side of the hole. When bubbles touch the lipid solution, they absorb a part of it on a phase border and take the excess lipids out of the hole. Wait for a few minutes; the membrane will stabilize and a straight line will be observed on the recording device, with the noise level around ±2-3 pA.  crItIcal step Do not place the air bubble over the hole, as this will rupture the bilayer.  crItIcal step Ensure that the thickness of the membrane is around the optimal value for these experiments, 5 nm. If the membrane is too thin, in fact, the connector channel will be unstable; if the membrane is too thick, the proteoliposomes will not fuse with the planar membrane.
76|
77|
For single conductance measurements, dilute the stock SUV solutions from Step 59 to 10-to 20-fold before use. Add 0.5-2 µl of the diluted liposome solution into the cis-compartment on top of the aperture. Wait for a few minutes for the proteoliposomes to fuse with the planar bilayer, thus inserting the connector channel(s) in the planar membrane (Fig. 4b) .  crItIcal step If too many channels are inserted in the membrane, they can negatively affect membrane stability. If membrane stability is compromised, repaint the membrane and wait for connector insertion.
78|
After the insertion of connector channels in the membrane, observe discrete stepwise increases in current to determine the single-channel conductance of the connector. Measure the conductance under constant potential, option A, or under varying potential, option B. The data obtained using the approach detailed in option B are more accurate, as the slope of the curve reporting current versus electrostatic potential, which represents the conductance of the system, is determined using several data points. Furthermore, the influence of electrode and contact potentials is excluded from the calculation.
(a) conductance measurement at constant potential (i) Derive the value of the conductance of the system at specific, constant potentials, and either positive or negative transmembrane voltage (we typically use 75 mV) using the ratio of the measured current jump induced by a discrete step to the applied voltage. Acquire and statistically analyze data from multiple channel insertion events (from multiple experiments) to obtain reliable values for the single-channel conductance of the connector. Plot a histogram (y axis: number of events versus x axis: conductance) to obtain the distribution for channel conductance (Fig. 4b,d ). (B) conductance measurement at varying (ramping) potential (i) Measure the conductance of the system by calculating the slope of the current-voltage trace. Do so by applying a ramping potential from − 100 mV to + 100 mV (Fig. 4c) . As an illustration, traces from one, two and three connector insertions under a ramp voltage are shown in Figure 4c 
80|
Add purified DNA to the BLM chamber by premixing it in the conducting buffer either before the connector-containing bilayer has been assembled in the chamber or after the connector-containing bilayer has already been assembled. Choose the second approach specifically to observe the instantaneous effects of adding DNA in real time.  crItIcal step Be aware that the orientation of the connector channel in the lipid membrane is random, because it relies on vesicle fusion of proteoliposomes with a planar bilayer to insert the channel in the membrane. The connector channel can, therefore, be oriented with either the C-terminal (wide) end or the N-terminal (narrow) end facing the trans-compartment. The orientation of the connector is important, because DNA traffic across the connector protein is one-directional (with DNA entry occurring at the protein's N-terminal end, and DNA exit at the C-terminal end) 22 ; Fig. 5 ).  crItIcal step Exercise caution when adding DNA after the connector-containing membrane has been assembled, as the membrane can rupture; switch the applied voltage of 0 mV and add DNA slowly. ? trouBlesHootInG 81| Record the current traces associated with DNA translocation at a moderate-to-high sampling frequency . In the presence of DNA, a burst of transient (temporary) current blockage events will be observed, as DNA, a non-electrolyte, physically blocks ion current (Fig. 5b) . Each of the events shown in the graph in Fig. 5b represents the translocation of a single DNA molecule. where I pore is the current when the connector channel is open (i.e., the step size of the current for one-connector insertion) and I DNA is the current observed during DNA translocation. In the presence of dsDNA, the channel blockage percentage will be ~32%, which is consistent with the dimensions of the channel (3.6 nm diameter at its narrowest end) and of dsDNA (~2 nm in diameter; Fig. 5c ). Dwell time is the time taken for the passage of DNA from one end of the channel to the other (Fig. 5b) . Dwell time distributions typically follow an exponential decay profile (Fig. 5d) .  crItIcal step Acquire and statistically analyze data on a large number of translocation events to obtain reliable values for the mentioned parameters.
82|
83|
To verify that the observed current blockage events indeed result from dsDNA translocation through the connector channel, add dsDNA to the trans-compartment to a final concentration of 25-100 nM, after the addition of connector/liposome complexes. As a negative control, add the DNA without the addition of connector/liposome complexes.
84|
Apply a potential of -95 mV and collect samples from the cis-compartment at specific time intervals (such as 30 min). 
85|
Determine the DNA concentration using a UV-vis spectrophotometer, and use this concentration to determine the copy number of DNA molecules (absolute quantification) in the samples collected.
86|
Perform quantitative PCR (qPCR) experiments using iQTM SYBR Green Supermix and the LightCycler 480 real-time PCR system. Use appropriate forward and reverse primers depending on the sequence for the dsDNA used in the experiment.
87| Construct a standard curve using dsDNA with tenfold dilutions of known concentrations and assay each dilution in triplicate (Fig. 6) . In the graph shown in Figure 6a , baseline-subtracted PCR curve-fits of relative fluorescence units for different DNA copy numbers (reported in the graph itself) are plotted against the PCR amplification cycle. The observed blockage events from the current trace should closely associate with the number of DNA molecules passing through the pores quantified by qPCR (Fig. 6e) , which will validate the DNA translocation experiments.  crItIcal step Generally speaking, as the number of connectors in the bilayer increases, so will DNA translocation events per unit time; however, given that DNA traffic across the connector is one directional, some of the channels that are in the 'wrong' orientation will not translocate DNA (Fig. 6b,c) . It is important to validate the inference that the increase of the DNA copy number in the cis-compartment is due to DNA translocation through the channels rather than membrane leakage. If the Teflon partition is leaking or the lipid bilayer ruptured during the course of the experiment, the copy number of DNA per µl of solution in the cis-compartment will be approximately 10 4 -to 10 5 -fold higher than those experiments without leakage (Fig. 6d) . After assembly, this mutation will result in the formation of a cysteine ring composed of 12 evenly spaced residues located in the same plane within the dodecameric connector channel (see .
(ii) Purify the reengineered connectors to homogeneity (see . (iii) Characterize the conductance properties of the reengineered connectors from multiple experiments (see Step 78) . For reference, C-His K234C channels have a smaller cross-sectional area (conductance: 2.2 ± 0.17 nS) than the C-His connectors without the mutation (conductance: 3.2 ± 0.2 nS) (iv) Use well-known methodologies to selectively conjugate chemicals to the sulfhydryl side chain of cysteines. Examples include chemicals containing maleimides and iodoacetamides that form C-S bonds; sulfhydryls that form disulfides under oxidizing conditions; and transthioesterification reactions linking synthesized thioesters to the channel cysteines 84 (Figs. 7 and 8) . (iii) If, for instance, a C-His-tag was added, to confirm that it is present, add rabbit polyclonal antibodies specific to the hexahistidine tag to the trans-compartment under asymmetric ionic conditions. Use 1 M NaCl and 20 mM Tris (pH 7.6) for the cis-compartment. Use 150 mM NaCl and 20 mM Tris (pH 7.6) in the trans-compartment to avoid the high-salt effect that might interfere with the binding of Nanogold to the His-tagged connector. Alternatively, add Ni-NTA-Nanogold (1.8 nm; Nanoprobes) to the trans-compartment under asymmetric ionic conditions. (iv) Monitor the binding of antibodies or Nanogold particles to the connector termini over time (see Step 89; Fig. 9 ).
89|
Characterize the binding events (from Step 88A and B) by monitoring the changes in current intensity in a BLM setup (Figs. 8 and 9) . Use the 'Current blockage amplitude' and 'current blockage signature' parameters as follows. For current blockage amplitude, observe the stepwise decrease in conductance associated with the binding of chemicals or macromolecules sequentially to each cysteine probe or C-terminal probe due to the physical hindrance of the channel (Figs. 7-9) . To obtain the current blockage signature, note that the characteristic signature of the captured analyte is the result of the unique blockage amplitude and the pattern of the signals. Count the number of molecules bound on the basis of the stepwise, sequential blockages observed and deduce the molecule concentration from the number of binding events to a single pore detected per unit time.  crItIcal step Acquire and statistically analyze data on a large number of single-molecule binding events.
? trouBlesHootInG Troubleshooting advice can be found in table 1. 
antIcIpateD results
In this protocol, we have provided an in-depth procedure for cloning, expressing and purifying the phi29 DNA-packaging motor connector and for inserting it into a lipid bilayer to serve as a model for a membrane-embedded nanopore. We have also provided general instructions on how to translocate DNA through the channel, append substrate-specific probes to the connector and to use conductance experiments to ascertain the presence of such substrates in solution. Explicit engineering of the phi29 connector is possible given that its crystal structure is available 28, 29 . Anticipated results of this protocol are as follows:
